Enterprise Value
428.7M
Cash
175.2M
Avg Qtr Burn
-19.03M
Short % of Float
3.40%
Insider Ownership
0.02%
Institutional Own.
91.02%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
PGN-EDO51 Details Duchenne muscular dystrophy | Phase 2 Data readout | |
PGN-EDODM1 Details Myotonic Dystrophy Type 1 | Phase 1 Data readout |